These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10434498)

  • 1. AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs.
    Gutgesell H; Atkins D; Barst R; Buck M; Franklin W; Humes R; Ringel R; Shaddy R; Taubert KA
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):1047-50. PubMed ID: 10434498
    [No Abstract]   [Full Text] [Related]  

  • 2. [QT interval prolongation and psychotropic drugs in children and adolescents: proposed guideline].
    van Aerde KJ; Kalverdijk LJ; Reimer AG; Widdershoven JA
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1765-70. PubMed ID: 18754307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of psychotropic medication for children in foster care.
    Crismon ML; Argo T
    Child Welfare; 2009; 88(1):71-100. PubMed ID: 19653454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association.
    Gutgesell H; Atkins D; Barst R; Buck M; Franklin W; Humes R; Ringel R; Shaddy R; Taubert KA
    Circulation; 1999 Feb; 99(7):979-82. PubMed ID: 10027824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
    Hebebrand J; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical clinical issues regarding child and adolescent psychopharmacology.
    Kutcher S
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):245-60. PubMed ID: 10674199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of psychotropic drugs on the cardiovascular system.
    Risch SC; Groom GP; Janowsky DS
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):16-31. PubMed ID: 6122680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular medications.
    Williams S; Wynn G; Cozza K; Sandson NB
    Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
    [No Abstract]   [Full Text] [Related]  

  • 11. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When the typical family doctor patient needs a psychotropic drug. The most important guidelines for therapy].
    Laux G
    MMW Fortschr Med; 2006 Nov; 148(46):26. PubMed ID: 17615783
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulants and sudden death: what is a physician to do?
    Wilens TE; Prince JB; Spencer TJ; Biederman J
    Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring in child and adolescent psychiatry.
    Egberts KM; Mehler-Wex C; Gerlach M
    Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving drug safety and tolerability in psychiatric clinical practice.
    Haddad PM; Dursun SM
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():S1-2. PubMed ID: 18098219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinically significant interactions of psychotropic drugs used in psychiatry].
    Szymura-Oleksiak J
    Pol Merkur Lekarski; 2000 Sep; 9(51):627-9. PubMed ID: 11126992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Off-label use of drugs in psychiatry and neurology].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart and mind: (2) psychotropic and cardiovascular therapeutics.
    Shah SU; Iqbal Z; White A; White S
    Postgrad Med J; 2005 Jan; 81(951):33-40. PubMed ID: 15640426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopharmaceuticals for children and adolescents are better than many seem to think].
    Nissen G
    MMW Fortschr Med; 2005 Dec; 147(48):31; quiz 47-8. PubMed ID: 16389858
    [No Abstract]   [Full Text] [Related]  

  • 20. Nursing management of psychotropic drug reactions.
    Wintz CJ
    Nurs Clin North Am; 1998 Mar; 33(1):217-31. PubMed ID: 9478916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.